Pra Health (PRAH) Stock Price & Overview
NASDAQ:PRAH
Current stock price
The current stock price of PRAH is 165.21 null. Today PRAH is down by -1.67%. In the past month the price decreased by -2.76%. In the past year, price increased by 73.81%.
PRAH Key Statistics
- Market Cap
- 10.705B
- P/E
- 32.65
- Fwd P/E
- 23.77
- EPS (TTM)
- 5.06
- Dividend Yield
- N/A
PRAH Stock Performance
PRAH Stock Chart
PRAH Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PRAH. When comparing the yearly performance of all stocks, PRAH is one of the better performing stocks in the market, outperforming 77.96% of all stocks.
PRAH Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PRAH. While PRAH is still in line with the averages on profitability rating, there are concerns on its financial health.
PRAH Earnings
PRAH Forecast & Estimates
4 analysts have analysed PRAH and the average price target is 171.11 null. This implies a price increase of 3.57% is expected in the next year compared to the current price of 165.21.
For the next year, analysts expect an EPS growth of 29.21% and a revenue growth 19.32% for PRAH
PRAH Groups
Sector & Classification
PRAH Financial Highlights
Over the last trailing twelve months PRAH reported a non-GAAP Earnings per Share(EPS) of 5.06. The EPS decreased by -1.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.4% | ||
| ROA | 4.98% | ||
| ROE | 13.71% | ||
| Debt/Equity | 0.74 |
PRAH Ownership
PRAH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 18.99 | 191.005B | ||
| DHR | DANAHER CORP | 19.29 | 130.245B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 142.85 | 46.991B | ||
| A | AGILENT TECHNOLOGIES INC | 16.84 | 34.045B | ||
| WAT | WATERS CORP | 20.97 | 32.826B | ||
| IQV | IQVIA HOLDINGS INC | 12.52 | 29.413B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.31 | 26.529B | ||
| ILMN | ILLUMINA INC | 23.85 | 19.824B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.54 | 19.78B | ||
| MEDP | MEDPACE HOLDINGS INC | 20.01 | 14.522B | ||
| RVTY | REVVITY INC | 16.58 | 10.541B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.958B | ||
| TECH | BIO-TECHNE CORP | 23.88 | 9.165B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PRAH
Company Profile
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. The company is headquartered in Raleigh, North Carolina and currently employs 18,100 full-time employees. The company went IPO on 2014-11-13. The firm provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The firm offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The company provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The firm's service offerings include product registration, strategic solutions and early development services.
Company Info
IPO: 2014-11-13
Pra Health
4130 Parklake Ave Ste 400
Raleigh NORTH CAROLINA 27612 US
CEO: Colin Shannon
Employees: 18100.0
Phone: 19197868200.0
Pra Health / PRAH FAQ
Can you describe the business of Pra Health?
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. The company is headquartered in Raleigh, North Carolina and currently employs 18,100 full-time employees. The company went IPO on 2014-11-13. The firm provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The firm offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The company provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The firm's service offerings include product registration, strategic solutions and early development services.
What is the current price of PRAH stock?
The current stock price of PRAH is 165.21 null. The price decreased by -1.67% in the last trading session.
Does Pra Health pay dividends?
PRAH does not pay a dividend.
What is the ChartMill rating of Pra Health stock?
PRAH has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for PRAH stock?
4 analysts have analysed PRAH and the average price target is 171.11 null. This implies a price increase of 3.57% is expected in the next year compared to the current price of 165.21.
Would investing in Pra Health be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRAH.
What is the market capitalization of PRAH stock?
Pra Health (PRAH) has a market capitalization of 10.70B null. This makes PRAH a Large Cap stock.